FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1925020692> ?p ?o ?g. }

• W1925020692 endingPage "71" @default.
• W1925020692 startingPage "63" @default.
• W1925020692 abstract "Macrophages are important drug targets as they mediate a wide variety of infectious diseases. Visceral leishmaniasis (VL), schistosomiasis, brucellosis, and salmonellosis are some of the well-known infectious diseases in which macrophages play a prominent pathophysiological role. For instance, VL parasites exclusively house in the macrophages of liver and spleen. They are resistant to lysosomal degradation by unknown mechanisms, they survive and thrive safely within macrophages, they multiply, and they ultimately affect visceral organs, leading to severe pathological and sometimes even fatal conditions. The majority of routinely used drugs administered in free form distribute all over the body via systemic circulation, leading to relatively low therapeutic activity and a certain degree of toxicity. Unlike for nonmicrobial diseases, targeting parasites procuring resistance and ineffective therapeutic outcome can be obviously speculated in case of infectious disease. The preferential uptake by macrophages, intended to improve the balance between efficacy and toxicity, can be achieved by the use of nanomedicines, i.e. submicron-sized macromolecular or particulate drug delivery systems. This insight has stimulated researchers to use nanomedicines--which tend to be recognized by macrophages as 'foreign' and consequently are taken up by the intended target cells much more effectively than their free drug counterparts--to improve the treatment of infectious diseases. The literature reports extensively on such approaches; however, there are several constraints that limit the application of nanomedicine in macrophage-mediated drug targeting. Here, we briefly describe the strategies that are used to achieve effective drug targeting to macrophages, using VL as a model disease, and we also put forth an understanding of the most important limiting factors. Various physicochemical and biological factors used by researchers as reported in the literature are addressed, and the most important mechanisms and modes by which macrophage-specific drug targeting can be achieved are summarized. Based on the evidence obtained to date, it can be concluded that targeting macrophages is a valuable and validated strategy for improving the treatment of infectious diseases." @default.
• W1925020692 created "2016-06-24" @default.
• W1925020692 creator A5000092676 @default.
• W1925020692 creator A5000469333 @default.
• W1925020692 creator A5023346320 @default.
• W1925020692 creator A5028314781 @default.
• W1925020692 creator A5034298071 @default.
• W1925020692 date "2011-06-01" @default.
• W1925020692 modified "2023-09-26" @default.
• W1925020692 title "Physicochemical and biological aspects of macrophage-mediated drug targeting in anti-microbial therapy" @default.
• W1925020692 cites W1499937829 @default.
• W1925020692 cites W1968601352 @default.
• W1925020692 cites W1972125324 @default.
• W1925020692 cites W1975861244 @default.
• W1925020692 cites W1997408488 @default.
• W1925020692 cites W2004109893 @default.
• W1925020692 cites W2010090942 @default.
• W1925020692 cites W2011295320 @default.
• W1925020692 cites W2015178572 @default.
• W1925020692 cites W2016587111 @default.
• W1925020692 cites W2020097101 @default.
• W1925020692 cites W2025822586 @default.
• W1925020692 cites W2039796373 @default.
• W1925020692 cites W2048206857 @default.
• W1925020692 cites W2056315834 @default.
• W1925020692 cites W2058928574 @default.
• W1925020692 cites W2070342688 @default.
• W1925020692 cites W2077783175 @default.
• W1925020692 cites W2078057254 @default.
• W1925020692 cites W2079302111 @default.
• W1925020692 cites W2085876947 @default.
• W1925020692 cites W2097709608 @default.
• W1925020692 cites W2103632818 @default.
• W1925020692 cites W2110023155 @default.
• W1925020692 cites W2117310409 @default.
• W1925020692 cites W2125791465 @default.
• W1925020692 cites W2142416382 @default.
• W1925020692 cites W2144346703 @default.
• W1925020692 cites W2222841413 @default.
• W1925020692 cites W2262760967 @default.
• W1925020692 cites W2430201478 @default.
• W1925020692 cites W4241313682 @default.
• W1925020692 cites W43622896 @default.
• W1925020692 cites W67744072 @default.
• W1925020692 doi "https://doi.org/10.1111/j.1472-8206.2011.00955.x" @default.
• W1925020692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21631585" @default.
• W1925020692 hasPublicationYear "2011" @default.
• W1925020692 type Work @default.
• W1925020692 sameAs 1925020692 @default.
• W1925020692 citedByCount "13" @default.
• W1925020692 countsByYear W19250206922013 @default.
• W1925020692 countsByYear W19250206922015 @default.
• W1925020692 countsByYear W19250206922016 @default.
• W1925020692 countsByYear W19250206922019 @default.
• W1925020692 countsByYear W19250206922020 @default.
• W1925020692 countsByYear W19250206922021 @default.
• W1925020692 countsByYear W19250206922023 @default.
• W1925020692 crossrefType "journal-article" @default.
• W1925020692 hasAuthorship W1925020692A5000092676 @default.
• W1925020692 hasAuthorship W1925020692A5000469333 @default.
• W1925020692 hasAuthorship W1925020692A5023346320 @default.
• W1925020692 hasAuthorship W1925020692A5028314781 @default.
• W1925020692 hasAuthorship W1925020692A5034298071 @default.
• W1925020692 hasConcept C126322002 @default.
• W1925020692 hasConcept C142724271 @default.
• W1925020692 hasConcept C15083742 @default.
• W1925020692 hasConcept C155672457 @default.
• W1925020692 hasConcept C171250308 @default.
• W1925020692 hasConcept C178790620 @default.
• W1925020692 hasConcept C185592680 @default.
• W1925020692 hasConcept C192562407 @default.
• W1925020692 hasConcept C202751555 @default.
• W1925020692 hasConcept C203014093 @default.
• W1925020692 hasConcept C2776555147 @default.
• W1925020692 hasConcept C2778689377 @default.
• W1925020692 hasConcept C2779134260 @default.
• W1925020692 hasConcept C2779244956 @default.
• W1925020692 hasConcept C2779820397 @default.
• W1925020692 hasConcept C2780035454 @default.
• W1925020692 hasConcept C2780931953 @default.
• W1925020692 hasConcept C29730261 @default.
• W1925020692 hasConcept C524204448 @default.
• W1925020692 hasConcept C55493867 @default.
• W1925020692 hasConcept C71924100 @default.
• W1925020692 hasConcept C86803240 @default.
• W1925020692 hasConcept C98274493 @default.
• W1925020692 hasConceptScore W1925020692C126322002 @default.
• W1925020692 hasConceptScore W1925020692C142724271 @default.
• W1925020692 hasConceptScore W1925020692C15083742 @default.
• W1925020692 hasConceptScore W1925020692C155672457 @default.
• W1925020692 hasConceptScore W1925020692C171250308 @default.
• W1925020692 hasConceptScore W1925020692C178790620 @default.
• W1925020692 hasConceptScore W1925020692C185592680 @default.
• W1925020692 hasConceptScore W1925020692C192562407 @default.
• W1925020692 hasConceptScore W1925020692C202751555 @default.
• W1925020692 hasConceptScore W1925020692C203014093 @default.
• W1925020692 hasConceptScore W1925020692C2776555147 @default.
• W1925020692 hasConceptScore W1925020692C2778689377 @default.

• next